REPLIGEN CORP Debt Instrument, Interest Rate, Effective Percentage
REPLIGEN CORP (RGEN) had Debt Instrument, Interest Rate, Effective Percentage of 1.00% as of 2023-09-30, per its 10-Q filed 2023-10-31.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateEffectivePercentage · last filed 2024-11-18
- 2023-09-30: Debt Instrument, Interest Rate, Effective Percentage 1.00%.
- 2023-06-30: Debt Instrument, Interest Rate, Effective Percentage 1.00%.
- 2023-03-31: Debt Instrument, Interest Rate, Effective Percentage 1.00%.
- 2022-09-30: Debt Instrument, Interest Rate, Effective Percentage 1.00%.
| Period end | Debt Instrument, Interest Rate, Effective Percentage | Debt Instrument, Interest Rate, Effective Percentage as first filed |
|---|---|---|
| 2023-09-30 | 1.00% 10-Q · filed 2023-10-31 | |
| 2023-06-30 | 1.00% 10-Q · filed 2023-08-02 | |
| 2023-03-31 | 1.00% 10-Q/A · filed 2024-11-18 | |
| 2022-09-30 | 1.00% 10-Q · filed 2023-10-31 | |
| 2022-06-30 | 1.00% 10-Q · filed 2023-08-02 | |
| 2022-03-31 | 1.00% 10-Q/A · filed 2024-11-18 | 0.30% 10-Q · filed 2022-04-27 |
| 2021-09-30 | 5.10% 10-Q · filed 2022-11-01 | |
| 2021-06-30 | 5.10% 10-Q · filed 2022-08-02 | |
| 2021-03-31 | 1.20% 10-Q · filed 2022-04-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |